Volume 9, Issue 2 (2024)                   SJMR 2024, 9(2): 129-133 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karamnia Far M. Management of Thrombocytopenia During Pregnancy: A Case Report. SJMR 2024; 9 (2) : 8
URL: http://saremjrm.com/article-1-338-en.html
Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
Abstract:   (936 Views)
Introduction: Thrombocytopenia during pregnancy is one of the most common hematological abnormalities, which may occur due to various obstetric or systemic disorders. This condition rarely results in life-threatening complications, and its management typically focuses on addressing the underlying cause. This study aims to present the management of thrombocytopenia in pregnancy through a case report conducted at Sarem Super-Specialty Hospital in Tehran.
Case Presentation: This case report describes a 37-year-old pregnant woman, G1P0Ab0, in her third trimester, diagnosed with idiopathic thrombocytopenic purpura (ITP). The patient was under continuous medical supervision and received corticosteroid therapy due to severe thrombocytopenia and coexisting hypothyroidism. At 38 weeks of gestation, an elective cesarean section was performed due to ITP and cephalopelvic disproportion. A healthy female neonate weighing 2860 grams with Apgar scores of 9/6 was delivered. Despite experiencing bradycardia and apnea within the first 24 hours, the neonate’s platelet counts and blood glucose levels were within the normal range.
Conclusion: The management of thrombocytopenia during pregnancy requires thorough evaluation of the underlying cause and continuous monitoring. In this case, a multidisciplinary approach led to the successful discharge of both the mother and the neonate in good general condition. This report highlights the importance of precise management in complex cases of thrombocytopenia during pregnancy.

 
Article number: 8
Full-Text [PDF 642 kb]   (312 Downloads)    
Article Type: Case Report | Subject: Pregnancy Care
Received: 2024/08/20 | Accepted: 2024/08/31 | Published: 2024/12/23

References
1. Pishko, A.M. and A.L. Marshall, Thrombocytopenia in pregnancy. Hematology, 2022. 2022(1): p. 303-311. [DOI:10.1182/hematology.2022000375] [PMID] []
2. SEBUWUFU, P., Factors associated with thrombocytopenia among pregnant women seeking antenatal care services in Homabay teaching and referral hospital in Homabay county, Kenya. 2024, Maseno university.
3. Cines, D.B. and L.D. Levine, Thrombocytopenia in pregnancy. Hematology 2014, the American Society of Hematology Education Program Book, 2017. 2017(1): p. 144-151. https://doi.org/10.1182/asheducation-2017.1.144 [DOI:10.1182/blood-2017-05-781971] [PMID] []
4. McCrae, K., Immune thrombocytopenia: no longer 'idiopathic'. Cleve Clin J Med, 2011. 78(6): p. 358-73. [DOI:10.3949/ccjm.78gr.10005] [PMID] []
5. Lämmle, B., et al., 100 years of thrombotic thrombocytopenic purpura: a story of death and life. Hämostaseologie, 2024. 44(01): p. 059-073. [DOI:10.1055/a-2223-9484] [PMID]
6. Mangla, A. and H. Hamad, Thrombocytopenia in Pregnancy, in StatPearls. 2024, StatPearls Publishing
7. Copyright © 2024, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Hussein Hamad declares no relevant financial relationships with ineligible companies.
8. ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstetrics & Gynecology, 2019. 133(3): p. e181-e193. [DOI:10.1097/AOG.0000000000003100]
9. Zainal, A., A. Salama, and R. Alweis, Immune thrombocytopenic purpura. Journal of community hospital internal medicine perspectives, 2019. 9(1): p. 59-61. [DOI:10.1080/20009666.2019.1565884] [PMID] []
10. Park, Y.H., Diagnosis and management of thrombocytopenia in pregnancy. Blood research, 2022. 57(S1): p. 79-85. [DOI:10.5045/br.2022.2022068] [PMID] []
11. Provan, D., et al., Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood advances, 2019. 3(22): p. 3780-3817. [DOI:10.1182/bloodadvances.2019000812] [PMID] []
12. Park, Y.H., Diagnosis and management of thrombocytopenia in pregnancy. Blood Res, 2022. 57(S1): p. 79-85. [DOI:10.5045/br.2022.2022068] [PMID] []
13. Reese, J.A., et al., Platelet counts during pregnancy. New England Journal of Medicine, 2018. 379(1): p. 32-43. [DOI:10.1056/NEJMoa1802897] [PMID] []
14. Bulletins-Obstetrics, C.o.P., ACOG practice bulletin no. 207: thrombocytopenia in pregnancy. Obstet Gynecol, 2019. 133(3): p. e181-e193. [DOI:10.1097/AOG.0000000000003100]
15. Mithoowani, S. and D.M. Arnold, First-line therapy for immune thrombocytopenia. Hämostaseologie, 2019. 39(03): p. 259-265. [DOI:10.1055/s-0039-1684031] [PMID]
16. Park‐Wyllie, L., et al., Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta‐analysis of epidemiological studies. Teratology, 2000. 62(6): p. 385-392. https://doi.org/10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z [DOI:10.1002/1096-9926(200012)62:63.0.CO;2-Z] [PMID]
17. Yildirim, Y., et al., Gestational diabetes mellitus in patients receiving long-term corticosteroid therapy during pregnancy. 2006. [DOI:10.1515/JPM.2006.053] [PMID]
18. Cuker, A. and H.A. Liebman, Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern. Research and Practice in Thrombosis and Haemostasis, 2021. 5(6): p. e12592. [DOI:10.1002/rth2.12592] [PMID] []
19. Eslick, R. and C. McLintock, Managing ITP and thrombocytopenia in pregnancy. Platelets, 2020. 31(3): p. 300-306. [DOI:10.1080/09537104.2019.1640870] [PMID]
20. Payne, S.D., et al., Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. American journal of obstetrics and gynecology, 1997. 177(1): p. 149-155. [DOI:10.1016/S0002-9378(97)70454-X] [PMID]
21. Waghmare, B.V. and S. Jajoo, Navigating Primary Immune Thrombocytopenia During Pregnancy: Management Strategies and Considerations: A Comprehensive Review. Cureus, 2024. 16(8). [DOI:10.7759/cureus.67284]
22. Dahiphale, S., et al., Navigating Primary Immune Thrombocytopenia During Pregnancy With Management Strategies and Considerations: A Comprehensive Review. Cureus, 2024. 16(8): p. e67449. [DOI:10.7759/cureus.67449]
23. Beltrami-Moreira, M., A. Sharma, and J.B. Bussel, Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management. Expert Review of Hematology, 2024. 17(9): p. 595-607. [DOI:10.1080/17474086.2024.2385481] [PMID]
24. Ramadan, M.K., et al., Severe gestational thrombocytopenia: a case report and brief review of the literature. Journal of Hematology, 2017. 5(4): p. 142-150. [DOI:10.14740/jh308w]
25. Sayed, G., et al., Case Report: Thrombopoietin receptor agonists in resistant thrombocytopenia in pregnancy: a case series and review of literature. Frontiers in Hematology, 2023. 2: p. 1180156. [DOI:10.3389/frhem.2023.1180156]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb